SESN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.140200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.165000E-01
Normal-vs-Stage2
2.244400E-01
Normal-vs-Stage3
2.378800E-01
Normal-vs-Stage4
7.354600E-01
Stage1-vs-Stage2
6.568400E-01
Stage1-vs-Stage3
1.384420E-01
Stage1-vs-Stage4
7.502000E-01
Stage2-vs-Stage3
1.61488999999015E-05
Stage2-vs-Stage4
4.302400E-01
Stage3-vs-Stage4
1.678370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.020600E-01
Normal-vs-AfricanAmerican
9.441200E-01
Normal-vs-Asian
7.423900E-02
Caucasian-vs-AfricanAmerican
1.108430E-01
Caucasian-vs-Asian
3.393800E-01
AfricanAmerican-vs-Asian
1.684160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.434800E-01
Normal-vs-Female
2.033000E-01
Male-vs-Female
8.654000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.181800E-01
Normal-vs-Age(41-60Yrs)
5.265600E-01
Normal-vs-Age(61-80Yrs)
1.318220E-01
Normal-vs-Age(81-100Yrs)
2.397600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.894600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.443800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.852400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.325800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.44709999999149E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.67729999999544E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.276300E-02
Normal-vs-Daily Drinker
2.838600E-01
Normal-vs-Weekly Drinker
3.257400E-01
Normal-vs-Occasional Drinker
1.620850E-01
Normal-vs-Social Drinker
6.426800E-01
Non Drinker-vs-Daily Drinker
5.115600E-01
Non Drinker-vs-Weekly Drinker
9.917200E-01
Non Drinker-vs-Occasional Drinker
2.085600E-01
Non Drinker-vs-Social Drinker
2.341400E-01
Daily Drinker-vs-Weekly Drinker
5.257800E-01
Daily Drinker-vs-Occasional Drinker
6.430100E-02
Daily Drinker-vs-Social Drinker
1.454210E-01
Weekly Drinker-vs-Occasional Drinker
2.184600E-01
Weekly Drinker-vs-Social Drinker
2.309000E-01
Occasional Drinker-vs-Social Drinker
5.684600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.141000E-01
Normal-vs-Grade 2
2.255600E-01
Normal-vs-Grade 3
2.172000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.917400E-01
Grade 1-vs-Grade 3
8.348000E-01
Grade 1-vs-Grade 4
2.141000E-01
Grade 2-vs-Grade 3
9.622200E-01
Grade 2-vs-Grade 4
2.255600E-01
Grade 3-vs-Grade 4
2.172000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.826190E-01
Normal-vs-NonDiabetic
1.548350E-01
Diabetic-vs-NonDiabetic
2.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.302150E-01
Normal-vs-NoPancreatitis
1.930560E-01
Pancreatitis-vs-NoPancreatitis
7.341400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.477000E-01
Normal-vs-N1
2.236400E-01
N0-vs-N1
9.609800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.284800E-01
Normal-vs-TP53-NonMutant
3.916600E-01
TP53-Mutant-vs-TP53-NonMutant
4.096000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
